CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Orion Infusion Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Orion Infusion Ltd
Orion House (2nd Floor)
153-154, Tejgaon 1/A
Phone: +880 28870133p:+880 28870133 DHAKA, 1208  Bangladesh Ticker: ORIONINFUORIONINFU

Business Summary
Orion Infusion Limited is a Bangladesh-based large volume parenteral (LVP) manufacturing company. The Company is a provider of medicines and health care services through approximately 28 brands and 42 presentations of various formulations. The Company is engaged in manufacturing and marketing of Intravenous (I.V.) fluid, lifesaving intravenous medicine and intravascular saline, which include fluid and nutrient, fluid and electrolyte, fat emulsion for I.V. use, fluid, nutrient and electrolyte, plasma substitute, antiulcerant, osmotic diuretic and amino acid solutions. The Company has the manufacturing facilities to produce I.V. Rehydration Solutions, Electrolyte Solutions, and Solution for Acidosis, Ranitidine I.V. infusion, Anti-Microbial products namely, Ciprofloxacin I.V., Metronidazole I.V. and others. The Company's production plant is situated at Maikuli, P.S. Rupganj, and District- Naraynganj, Bangladesh.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20246/30/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

General Information
Number of Employees: 712 (As of 6/30/2016)
Outstanding Shares: 20,359,760 (As of 3/31/2024)
Shareholders: 5,032
Stock Exchange: DSE
Fax Number: +880 28870130


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024